Výsledky vyhledávání - "Shinji Ohono"

Randomized phase II study of weekly paclitaxel with and without carboplatin followed by cyclophosphamide/epirubicin/5-fluorouracil as neoadjuvant chemotherapy for stage II/IIIA breast cancer without HER2 overexpression

Autor: Masashi Ando, Kenjiro Aogi, Hideko Yamauchi, Satoru Shimizu, Kenichi Inoue, Shinji Ohono, Tetsutaro Hamano, Yasuhiro Fujiwara, Tamie Sukigara, Norikazu Masuda, Hiroji Iwata, Naohito Yamamoto, Katsumasa Kuroi

Publikováno v: Breast Cancer Research and Treatment. 145:401-409

Addition of carboplatin to neoadjuvant chemotherapy in HER2-negative breast cancer may improve pathological complete response (pCR) rates. We evaluated the efficacy and safety of carboplatin and weekly paclitaxel (wPTX) followed by cyclophosphamide,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba4f5820638d7f106f10aac89809a8fe
https://doi.org/10.1007/s10549-014-2947-1

Zobrazit plný text záznamu

A close association between alteration in growth kinetics by neoadjuvant chemotherapy and survival outcome in primary breast cancer

Autor: Masahiro Takada, Nobuaki Funata, Kazumi Toyama, Takayuki Ueno, Masakazu Toi, Sigeru Murakami, Shinichiro Horiguchi, Stig Linder, Shinji Ohono, Junko Kinoshita, Shigehira Saji, Akemi Kataoka, Hiroko Bando, Yukiko Hayashi

Publikováno v: International journal of oncology. 25(2)

Few surrogate markers are available for predicting the survival benefit from chemotherapy in primary breast cancer. We examined tumor growth kinetics by assessing cytokeratin 18 neo-epitope (CK18NE), an apoptosis marker detected by M30 antibody and K

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47b158486eb42393364a373e7a53fed0
https://pubmed.ncbi.nlm.nih.gov/15254737

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání